Capecitabine combined with gemcitabine (CapGem) as first‐line treatment in patients with advanced/metastatic biliary tract carcinoma - Concepedia

Concepedia

Publication | Open Access

Capecitabine combined with gemcitabine (CapGem) as first‐line treatment in patients with advanced/metastatic biliary tract carcinoma

DOI Full Paper Access

109

Citations

21

References

2005

Year

Yong Han Paik, Yoon Soo Chang, Se Joon Lee, Dong Ki Lee, Si Young Song, Moon Jae Chung, Mi‐Suk Park, Jeong‐Sik Yu, Dong Sup Yoon

Abstract

CapGem is an active and well tolerated first-line combination chemotherapy regimen for patients with advanced/metastatic biliary tract carcinoma that offers a convenient home-based therapy.

References

	Year	Citations
Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue Masanori Miwa, Masako Ura, M Nishida, European Journal of Cancer Medicinal ChemistryCancer TissueMedicinePharmacologyHuman Liver	1998	1.2K
One-Sample Multiple Testing Procedure for Phase II Clinical Trials Thomas R. Fleming Biometrics Surgical OncologyClinical EndpointMetronomic ChemotherapyTranslational MedicineClinical Trials	1982	993
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials Eric Van Cutsem, Paulo M. Hoff, Peter Harper, British Journal of Cancer	2004	396
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study Thierry André, Christophe Tournigand, Olivier Rosmorduc, Annals of Oncology Gastrointestinal OncologyMedicineBiliary CancerPathologyCancer Treatment	2004	381
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer. Melanie Mackean, André Planting, Chris Twelves, Journal of Clinical Oncology	1998	266
Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine. Daniel R. Budman, Neal J. Meropol, Bruno Reigner, Journal of Clinical Oncology	1998	257
Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer Geoffrey Falkson, John Macintyre, Charles G. Moertel Cancer Surgical OncologyCancer ManagementGastroenterologyPathologySurgery	1984	219
Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer T.W. Kim, Yoon‐Koo Kang, Jung‐Hyuck Ahn, Annals of Oncology OncologyGastrointestinal OncologyAdvanced Gastric CancerMedicinePhase Ii Study	2002	195
Phase I-II Study of Gemcitabine and Fluorouracil as a Continuous Infusion in Patients With Pancreatic Cancer Manuel Hidalgo, Daniel Castellano, Luis Paz‐Ares, Journal of Clinical Oncology	1999	178
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer M. Penz, Gabriela Kornek, Markus Raderer, Annals of Oncology UrologySurgical OncologyPhase Ii TrialGastrointestinal OncologyMedicine	2001	176

Page 1